Political, economic tensions in Malawi threaten new HIV/AIDS strategy

NewsGuard 100/100 Score

In a guest post on the GlobalPost's "Global Pulse" blog, Janet Fleischman, a senior associate at the CSIS Global Health Policy Center, describes the Malawian government's "plans to launch a 'test and treat' program in which all HIV-infected pregnant women will immediately be put on antiretroviral treatment (ART) drugs for life." But she adds that "[t]he growing political and economic crisis in Malawi, highlighted by the government's use of force against peaceful demonstrators last week, could also imperil the groundbreaking expansion of Malawi's national HIV/AIDS program."

"The implementation of Malawi's new strategy faces many challenges," but "the new approach also presents opportunities to address HIV/AIDS in Malawi," she writes. "It is not clear what impact [the political and economic situation] will have on the relationship between the government of Malawi and its key international donors," Fleischman says, concluding, "What is clear is that Malawi cannot hope to achieve its new HIV/AIDS targets without significant international support" (7/29).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Sugar abnormalities in the blood may promote biological aging and inflammation in HIV patients